Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus
A clinical trial update indicates that the linagliptin study in Filipino patients with Type 2 diabetes mellitus was terminated, with results…
-
CLINICAL_TRIALS research · 2014-09-18Clinical Trial Update: Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus [NA]
This entry outlines a clinical trial evaluating how various anesthesia methods influence the stress response during laparoscopic gastric byp…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Multiple Dose Study Of PF-05231023 In Obese Adult Subjects [Phase 1]
A Phase 1 multiple-dose study of PF-05231023 in obese adults (including those with Type 2 Diabetes Mellitus) was terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Action to Control Cardiovascular Risk in Diabetes (ACCORD) [Phase 3]
Phase 3 ACCORD trial evaluating strategies to reduce cardiovascular risk in people with diabetes; results were posted in 2014. The study inv…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) [Phase 4]
Phase 4 trial comparing sitagliptin/metformin fixed-dose combination to glimepiride in adults with type 2 diabetes mellitus; results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company, with the submission involving a diluent component.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: LIraglutide and Beta-cell RepAir (LIBRA) Study [Phase 3]
Phase 3 LIBRA trial evaluating liraglutide for Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Application and Effectiveness Analysis of Internet-based Diabetes Prevention Program [Phase 4]
Phase 4 study evaluating an Internet-based Diabetes Prevention Program for individuals with Type 2 diabetes and analyzing its application an…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis [Phase 2]
The document reports the completion of a Phase 2 clinical trial assessing Tang Ning Tongluo Formula in patients with Type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin [NA]
Clinical trial update on blood monitoring and data acquisition/utilization in patients with Type 2 diabetes mellitus treated with insulin. T…
-
CLINICAL_TRIALS other · 2014-09-11Clinical Trial Update: Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System [NA]
A clinical trial comparing an Internet-based blood glucose monitoring system with a continuous glucose monitoring system for Type 2 diabetes…
-
CLINICAL_TRIALS research · 2014-09-11Clinical Trial Update: Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment [NA]
A clinical trial update investigating pharmacological enhancement of brown adipose tissue function in type 2 diabetes mellitus and obesity.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update reporting results on the pharmacokinetics of triglyceride-rich lipoproteins ApoB48 and ApoB100 in patients wit…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2 [Phase 4]
A Phase 4 trial update from Karolinska Institutet evaluating the effect of Vitamin D (cholecalciferol) on beta cell function and insulin sen…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Insulinotropic Effect of GLP-1 and GIP After Dexamethasone [NA]
A completed trial in individuals with Type 2 diabetes investigated the insulinotropic effects of the incretin hormones GLP-1 and GIP after e…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects [Phase 2]
A Phase 2 trial update reporting the acute (after first dose) and chronic (after 28 days) effects of empagliflozin on pre- and postprandial …
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus [Phase 1]
This completed Phase 1 trial evaluated safety, pharmacokinetics, and pharmacodynamics of a single dose of CNTO 3649 in healthy adult men and…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: iDecide.Decido: Diabetes Medication Decision Support Study [NA]
The University of Michigan completed a clinical trial evaluating the iDecide.Decido diabetes medication decision-support study for adults wi…
-
CLINICAL_TRIALS research · 2014-09-09Clinical Trial Update: Low Glycemic Load Diets in Latino Children at Risk for Type 2 Diabetes [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating low glycemic load diets in Latino children at risk for…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Dietary Polyphenols and Lipid Oxidation [NA]
A completed clinical trial from Maastricht University Medical Center examined the effects of dietary polyphenols on lipid oxidation in indiv…
-
CLINICAL_TRIALS research · 2014-09-08Clinical Trial Update: A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM
This is a completed non-interventional study sponsored by AstraZeneca evaluating diabetes-related quality of life and the frequency and impa…
-
FDA approval · 2014-09-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approves a supplemental application for LANTUS SOLOSTAR (insulin glargine) by Sanofi-U.S. LLC.
-
FDA approval · 2014-09-04FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart mix 70/30) from Novo Nordi…